Diagnosis and management of placenta accreta in induced abortion of the second trimester

doi:10.3969/j.issn.1006-7795.2013.04.029

Abstract

Abstract:

Placenta accreta is a severe complication of pregnancy that is significant contributor to postpartum hemorrhage and maternal morbidity. It becomes currently the most common indication for peripartum hysterectomy due to massive hemorrhage. Even in the artificial abortion of the second trimester, we face the risk of placenta accreta as well. In this article, we review the epidemiology, etiology, diagnosis and management of placenta accreta, especially the high risk factors and diagnosis. The managements include operations and medications. Operation treatments include B-mode ultrasound guided dilatation and curettage, local resection by laparotomy or hysteroscopy, hysterectomy and transcatheter artery embolization. Medications include methotrexate, mifepristone, 5-fluorouracil(5-Fu), ethacridine, Chinese traditional medicine and so on. On account of the fertility desire of women who need induced abortion in the second trimester, the diagnosis of the placenta accreta should be made as soon as possible according to the screening for predisposing factors and careful examination both in prenatal phase and abortion. Conservative management should be considered first with caution to preserve fertility as far as possible.

Key words: placenta accreta, diagnosis, management

CLC Number:

R714.46⁺2

LUO Lanrong, LI Jian. Diagnosis and management of placenta accreta in induced abortion of the second trimester[J]. Journal of Capital Medical University, 2013, 34(4): 623-628.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2013.04.029

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2013/V34/I4/623

References

[1] Machado L S. Emergency peripartum hysterectomy: incidence, indications, risk factors and outcome[J]. N Am J Med Sci, 2011,3(8):358-361.

[2] Konijeti R, Rajfer J, Askari A. Placenta percreta and the urologist[J]. Rev Urol, 2009,11(3):173-176.

[3] 张超,刘欣燕,范光升,等.中晚期妊娠胎盘植入患者的临床分析[J].中华妇产科杂志,2008,43(7):506-511.

[4] Fitzpatrick K E, Sellers S, Spark P, et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study[J]. PLoS ONE, 2012,7(12):e52893.

[5] 肖中苏,谢建平.前置胎盘、胎盘粘连、胎盘植入与人工流产的关系[J].实用预防医学,2007,14(6):1831-1832.

[6] 周莉,吴连方.40例植入性胎盘的回顾性分析[J].首都医科大学学报,2005,26(1):90-94.

[7] Tseng J J, Chou M M, Hsieh Y T, et al. Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accrete[J]. Placenta, 2006,27(1):70-78.

[8] Beuker J M, Erwich J J, Khong T Y. Is endomyometrial injury during termination of pregnancy or curettage following miscarriage the precursor to placenta accreta?[J]. Clin Pathol, 2005,58(3):273-275.

[9] Hung T H, Shau W Y, Hsien C C, et al. Risk factors for placenta accreta[J]. Obstet Gynecol, 1999,93(4):545-550.

[10] 马菊秋,何雪冬,吴为玲.植入性胎盘23例临床分析[J].实用妇产科杂志,2009,25(7):442-444.

[11] 邹晓琴,叶卫莲,黄友琼.植入性胎盘产前诊断[J].河北医学,2011,17(5):629-633.

[12] Ophir E, Tendler R, Odeh M, et al. Creatine kinase as a biochemical marker in diagnosis of placenta increta and percreta[J]. Am J Obstet Gynecol, 1999,180(4):1039-1040.

[13] 孙江川,董晓静,刘建,等.胎盘植入产妇血清肌酸激酶的变化[J].实用妇产科杂志,2006,22(10):614-617.

[14] Sekizawa A, Jimbo M, Saito H, et al. Increased cell-free fetal DNA in plasma of two women with invasive placenta[J]. Clin Chem, 2002,48(2):353-354.

[15] Kadasne A R, Mirghani H M. The role of ultrasound in life-threatening situations in pregnancy[J]. J Emerg Trauma Shock, 2011,4(4):508-510.

[16] Comstock C H. Antenatal diagnosis of placenta accreta: a review[J]. Ultrasound Obstet Gynecol, 2005,26(1):89-96.

[17] 杨洁,徐莉,陈敦金,等.彩超和磁共振成像诊断胎盘植入价值的评价[J].现代妇产科进展,2008,17(7):530-532.

[18] Dwyer B K, Belogolovkin V, Tran L, et al. Prenatal diagnosis of placenta accreta: sonography or magnetic resonance imaging?[J]. J Ultrasound Med, 2008,27(9):1275-1281.

[19] 张力,李萍,何国琳,等.经腹彩色超声多普勒在前置胎盘并发胎盘植入诊断中的价值[J].中华妇产科杂志,2006,41(12):799-783.

[20] 彭软,谢红宁,杨建波,等.胎盘植入的产前超声诊断及其影响因素研究[J].中国临床医学影像杂志,2010,21(1):67-71.

[21] Vyshka G, Capari N, Shaqiri E. Placenta increta causing hemoperitoneum in the 26th week of pregnancy: a case report[J]. J Med Case Rep, 2010,4:412.

[22] 赵扬玉.剖宫产术后瘢痕部位穿透性胎盘植入[J].中国妇产科临床杂志,2009,10(4):245-249.

[23] 俞梅,刘欣燕,戴婧,等.中孕期胎盘植入的诊断和治疗[J].中国医学科学院学报,2010,32(5):501-504.

[24] Kayem G, Davy C, Goffnet F, et al. Conservative versus extirpative management in cases of placenta accrete[J]. Obstet Gynecol, 2004,104(3):531-536.

[25] 王琳,常青,江露.15例胎盘植入的手术治疗[J].重庆医学,2004,33(5):684-686.

[26] 姚丽凤,张红梅,胡艳,等.中孕引产失败8例临床分析[J].中国实用医药,2012,7(22):83-85.

[27] Son G, Kwon J, Cho H, et al. A case of placenta increta presenting as delayed postabortal intraperitoneal bleeding in the first trimester[J]. J Korean Med Sci, 2007,22(5):932-935.

[28] 胡艳妍,李东蔚.超声引导清宫治疗胎盘植入的临床价值[J].国际医药卫生导报,2011,17(9):1081-1083.

[29] 蔡平平,王谢桐,李克勤.超声波引导下局部注射MTX联合中药口服治疗植入性胎盘疗效观察[J].山东医药,2010,50(46):62-63.

[30] 罗利,黄毅岚,谭世桥,等.胎盘植入25例临床分析[J].实用妇产科杂志,2007,23(9):564-567.

[31] Tikkanen M, Stefanovic V, Paavonen J. Placenta previa percreta left in situ-management by delayed hysterectomy: a case report[J]. J Med Case Rep, 2011,5:418.

[32] 林开清,黄秀峰,张信美,等.宫腔镜电切术治疗部分性胎盘植入七例临床分析[J].中华妇产科杂志,2010,45(2):145-149.

[33] 陈春林,马奔,方艺川,等.动脉导管栓塞术在难治性产后出血中的应用[J].中华妇产科杂志,2001,36(3):133-141.

[34] 袁春桃,张翔.植入性胎盘36例治疗分析[J].实用妇产科杂志,2009,25(11):690-692.

[35] 赵英琦,任金凤.中期妊娠引产过程发现胎盘植入4例报告[J].山东医药,2008,48(18):89-90.

[36] 张国福,尚鸣异,韩志刚,等.子宫动脉化疗栓塞联合清宫术在胎盘植入保守治疗中的应用[J].介入放射学杂志,2010,19(12):947-950.

[37] Steins Bisschop C N, Schaap T P, Vogelvang T E, et al. Invasive placentation and uterus preserving treatment modalities, a systematic review[J]. Arch Gynecol Obstet, 2011,284(2):491-502.

[38] 王彤洁.米非司酮治疗胎盘植入50例观察[J].中国实用药,2009,4(32):116-118.

[39] 马振芳,邢明辉,王德芬.米非司酮在植入性胎盘中的应用[J].上海医学,2001,24(9):558-559.

[40] 刘春萍.胎盘植入保守治疗5例报告[J].医学文选,2001,20(3):323.

[41] 刘晓燕,姜云霞,隋延霞,等.依沙吖啶宫腔注入法治疗胎盘植入的临床观察[J].中国基层医药,2006,13(9):1419-1421.

[42] 田德明,岳艳,闻明,等.天花粉在30例胎盘植入中应用价值探讨[J].中国临床实用医学,2010,4(6):81-83.

[43] 杨静娴,牛和平.结晶天花粉蛋白保守治疗植入性及中央型前置胎盘[J].实用妇产科杂志,1995,11(2):99-100.

[44] 倪荣萍.胎盘植入的药物治疗进展[J].临床合理用药,2012,5(7A):349-351.